Talkspace, Inc. (NASDAQ: TALK)

Sector: Healthcare Industry: Health Information Services CIK: 0001803901
Market Cap 541.56 Mn
P/B 4.96
P/E 127.67
P/S 2.52
ROIC (Qtr) -0.10
Div Yield % 0.00
Rev 1y % (Qtr) 25.28
Total Debt (Qtr) 0.00
Debt/Equity (Qtr) 0.00
Add ratio to table...

About

Talkspace, Inc. (NASDAQ: TALK), a prominent player in the behavioral healthcare industry, has revolutionized the way patients access mental health services. The company, established in 2012, has facilitated connections between millions of patients and licensed mental health providers through messaging, video, and audio platforms. Initially incorporated as Hudson Executive Investment Corp., Talkspace took its current form following a merger with Groop Internet Platform, Inc. Talkspace's primary business activities revolve around providing psychotherapy...

Read more

Investment thesis

Bull case

  • Tangible assets of 129.06M provide exceptional 41.47x coverage of deferred revenue 3.11M, showing strong service capability backing.
  • Short-term investments of 52.10M provide solid 5.34x coverage of other current liabilities 9.76M, indicating strong liquidity.
  • Tangible assets of 129.06M provide robust 13.22x coverage of other current liabilities 9.76M, indicating strong asset backing.
  • Cash reserves of 43.65M provide robust 2.25x coverage of current liabilities 19.38M, indicating strong short-term solvency.
  • Strong cash position of 43.65M provides 4.47x coverage of other current liabilities 9.76M, indicating excellent liquidity.

Bear case

  • Operating cash flow of 7.24M barely covers its investment activities of (60.60M), with a coverage ratio of -0.12, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Investment activities of (60.60M) provide weak support for R&D spending of 9.92M, which is -6.11x, suggesting potentially insufficient investment in innovation relative to other capital deployment.
  • The company's operating cash flow of 7.24M shows concerning coverage of stock compensation expenses of 8.41M, with a 0.86 ratio indicating potential earnings quality issues.
  • Free cash flow of (1.78M) provides weak coverage of capital expenditures of 9.02M, with a -0.20 ratio suggesting additional external financing needs for growth initiatives.
  • Operating earnings of (108000) show weak coverage of depreciation charges of 2.26M, with a -0.05 ratio indicating high capital intensity and potential reinvestment needs.

Peer comparison

Companies in the Health Information Services
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 GEHC GE HealthCare Technologies Inc. 37.32 Bn 16.66 1.87 10.00 Bn
2 TEM Tempus AI, Inc. 35.72 Bn -175.20 32.32 1.34 Bn
3 VEEV Veeva Systems Inc 28.87 Bn 33.55 9.37 0.09 Bn
4 BTSG BrightSpring Health Services, Inc. 7.67 Bn 59.17 0.62 2.70 Bn
5 HQY Healthequity, Inc. 6.45 Bn 33.65 5.00 1.03 Bn
6 DOCS Doximity, Inc. 4.63 Bn 19.35 7.26 0.01 Bn
7 WAY Waystar Holding Corp. 4.33 Bn 38.59 3.93 1.49 Bn
8 PRVA Privia Health Group, Inc. 2.67 Bn 147.20 1.31 0.01 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 3.78 1.94
EV to Cash from Ops. EV/CFO 67.30 -6.03
EV to Debt EV to Debt 0.00 145.43
EV to EBIT EV/EBIT -4,511.30 -101.02
EV to EBITDA EV/EBITDA 226.30 2.47
EV to Free Cash Flow [EV/FCF] EV/FCF -273.57 3.97
EV to Market Cap EV to Market Cap 0.90 -28.84
EV to Revenue EV/Rev 2.27 -0.03
Price to Book Value [P/B] P/B 4.96 7.66
Price to Earnings [P/E] P/E 127.67 98.34
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Dividend Coverage Ratio 0.00 -8.72
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 5.01
Dividend per Basic Share Div per Share (Qtr) 0.00 0.04
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 4.56
Interest Coverage Int. cover (Qtr) 0.02 -584.72
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) -139.38 -23.97
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) -63.31 167.20
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 -1.33
EBIAT Growth (1y) % EBIAT 1y % (Qtr) 98.82 -19.20
EBITDA Growth (1y) % EBITDA 1y % (Qtr) 132.07 40.04
EBIT Growth (1y) % EBIT 1y % (Qtr) 98.59 -39.33
EBT Growth (1y) % EBT 1y % (Qtr) 470.99 6.33
EPS Growth (1y) % EPS 1y % (Qtr) 400.00 8.83
FCF Growth (1y) % FCF 1y % (Qtr) -176.60 -6.20
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) 8.60 4.96
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 1.66 0.66
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.03
Cash Ratio Cash Ratio (Qtr) 2.25 1.81
Current Ratio Curr Ratio (Qtr) 5.91 3.20
Debt to Equity Ratio Debt/Equity (Qtr) 0.00 -0.43
Interest Cover Ratio Int Coverage (Qtr) 0.02 -584.72
Times Interest Earned Times Interest Earned (Qtr) 0.02 -584.72
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 1.00 -435.68
EBIT Margin % EBIT Margin % (Qtr) -0.05 -464.60
EBT Margin % EBT Margin % (Qtr) 2.07 -461.63
Gross Margin % Gross Margin % (Qtr) 43.30 44.04
Net Profit Margin % Net Margin % (Qtr) 2.00 -467.91